fluorouracil has been researched along with Carcinoma, Oat Cell in 86 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Excerpt | Relevance | Reference |
---|---|---|
"Fifty-four patients with adenocarcinoma and large cell carcinoma of the lung, 16 with localized surgically resected disease and 38 with metastatic disease, were treated with 5-fluorouracil, doxorubicin, and mitomycin-C (FAM), in an attempt to prolong previously reported survival times in the patients." | 7.67 | 5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung. ( Shaw, MK; Shaw, MT, 1987) |
"Sixty-three previously untreated patients with metastatic non-small cell lung cancer (40 patients with adenocarcinoma and 23 with large cell undifferentiated carcinoma) were treated with combination chemotherapy consisting of 5-FU (300 mg/m2) given as an iv bolus on Days 1-4 and vindesine (3 mg/m2) and mitomycin (10 mg/m2), both given as an iv bolus on Day 1 of each treatment course (FEMi)." | 7.66 | Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study. ( Carlin, DA; Grozea, PN; Miller, TP; Weick, JK, 1982) |
"Using a randomized prospective trial design, chemotherapy with 5-fluorouracil, vincristine, and mitomycin C (FOMi) was compared with cyclophosphamide, doxorubicin, and cisplatin (CAP) and with FOMi alternating with CAP (FOMi/CAP) in 452 eligible patients with metastatic large-cell undifferentiated and adenocarcinoma of the lung." | 5.06 | Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study. ( Chen, TT; Coltman, CA; Fletcher, WS; Livingston, RB; Miller, TP; O'Bryan, RM; Stephens, RL; Vance, RB; Weiss, GB, 1986) |
" Treatment regimens usually employed cis-diammine-dichloroplatinum (CDDP) plus peplomycin for squamous cell carcinoma, and CDDP plus vindesine for adenocarcinoma." | 3.67 | [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion]. ( Inoue, F; Mimura, H; Miyake, M; Mori, T; Orita, K; Takeda, I; Tanaka, N, 1988) |
"The watery diarrhea-hypokalemia-achlorhydria syndrome associated with ectopic secretion of vasoactive intestinal peptide has only been conclusively documented with tumors originating in the pancreas or sympathetic chain." | 3.67 | Watery diarrhea-hypokalemia-achlorhydria syndrome and carcinoma of the esophagus. ( Douglas, MC; Hurley, R; Kalnins, R; Moran, L; Shulkes, A; Smallwood, RA; Watson, KJ, 1985) |
"Fifty-four patients with adenocarcinoma and large cell carcinoma of the lung, 16 with localized surgically resected disease and 38 with metastatic disease, were treated with 5-fluorouracil, doxorubicin, and mitomycin-C (FAM), in an attempt to prolong previously reported survival times in the patients." | 3.67 | 5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung. ( Shaw, MK; Shaw, MT, 1987) |
"Sixty-three previously untreated patients with metastatic non-small cell lung cancer (40 patients with adenocarcinoma and 23 with large cell undifferentiated carcinoma) were treated with combination chemotherapy consisting of 5-FU (300 mg/m2) given as an iv bolus on Days 1-4 and vindesine (3 mg/m2) and mitomycin (10 mg/m2), both given as an iv bolus on Day 1 of each treatment course (FEMi)." | 3.66 | Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study. ( Carlin, DA; Grozea, PN; Miller, TP; Weick, JK, 1982) |
"To observe the complementary function of moxibustion and Guben Yiliu III (GBYL), a Chinese herbal composite preparation, in combination with chemotherapy." | 2.70 | [Study on effect of moxibustion and guben yiliu III combined with chemotherapy in treating middle-late stage malignant tumor]. ( Liu, J; Rao, XQ; Yu, RC, 2001) |
" The dosage schedule was cisplatinum 100 mg/m2 D1 and 5-FU 1 g/m2 D1 to D5 every 3 weeks for 3 courses before evaluation." | 2.66 | [Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer]. ( Abouz, D; Ayela, P; Berthaud, P; Frenay, M; Lagrange, JL; Le Chevalier, T; Pujol, JL; Rivière, A; Robillard, J, 1989) |
" During the past eleven years, we have used postoperative chemotherapy in three ways over three different periods: in the earliest period, short-term combined chemotherapy (STCC) was used, in the middle period, intermittent long-term combined chemotherapy (ILTCC) was used in combination with immunotherapy for a randomized group, and in the latest period, when continuous long-term combined chemotherapy (CLTCC) with immunotherapy was employed." | 2.66 | [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy]. ( Hashizume, Y; Ichihashi, T; Iida, S; Kimoto, H; Kobayashi, H; Sato, H; Shimizu, J; Tsunamura, Y; Watanabe, Y; Yamada, T, 1985) |
" The polychemotherapy was given as a high dosage intermittent stosstherapy with 3 infusions at intervals of a week for 3 years." | 2.64 | [The combined treatment of bronchial carcinoma (author's transl)]. ( Karrer, K; Pridun, N, 1975) |
" He was treated with chemotherapy of 5-FU and Cisplatin combined with radiotherapy." | 1.30 | [A case report of esophageal small cell carcinoma responding well to chemotherapy of 5-FU and cisplatin combined with radiotherapy]. ( Kato, H; Nikkuni, K; Sasaki, K; Satoh, T; Tomidokoro, T; Yoshikawa, T, 1999) |
"We assessed the antiproliferative effect of human recombinant interferon -alpha (IFN-alpha) or -beta in combination with 5-fluorouracil (5-FU), cisplatin, or cis- or trans-retinoic acid on two human nonsmall cell lung carcinoma cell lines (SK-LU-1 and SK-MES-1) and on one human small cell lung carcinoma cell line (NCI-H69)." | 1.29 | Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines. ( Arbaje, YM; Bittner, G; Schiller, JH; Storer, B; Yingling, JM, 1993) |
"The palliative effects on dysphagia of radiotherapy (RT) and chemotherapy (CT) were evaluated retrospectively and compared with the effect of the self-expanding stent, evaluated in the prospective study." | 1.29 | Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment. ( Albertsson, M; Cwikiel, M; Cwikiel, W, 1996) |
"Monocytes from untreated breast cancer patients released significantly less hydrogen peroxide than controls (Breast = 75 +/- 17." | 1.28 | The effect of cancer and chemotherapy on monocyte function. ( Baughman, RP; Lower, EE, 1990) |
" From 1980 to 1982, 96 patients with SCLC were treated, 37 of whom by chemotherapy combined with surgery." | 1.27 | [Chemotherapy combined with selective resection in small cell lung cancer--analysis of 239 patients]. ( Cao, YF; Chen, YR; Fang, MS; Huang, OL; Liao, ML; Wu, SC; Wu, SF; Wu, SZ; Xu, CW; Yang, XF, 1986) |
"Nine patients had squamous cell carcinoma, two adenocarcinoma, and two large cell carcinoma." | 1.27 | [Postoperative chemotherapy of pathological stage I non-small cell carcinoma of the lung]. ( Kikuchi, K; Ogata, T, 1986) |
" Dose-response relationships of 3 triple-drug combinations and their component agents were explored, allowing the relative contributions of single agents in each combination to be assessed." | 1.26 | Experimental combination and single-agent chemotherapy in human lung-tumour xenografts. ( Jones, JM; Peckham, MJ; Shorthouse, AJ; Steel, GG, 1982) |
"Oat cell carcinoma is the one variety of primary lung cancer which is sufficiently responsive to a variety of drugs and drug combinations that a very high rate of response and significant prolongation of survival can be consistently achieved." | 1.26 | Chemotherapy for lung cancer. ( Golbey, RB, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 45 (52.33) | 18.7374 |
1990's | 20 (23.26) | 18.2507 |
2000's | 16 (18.60) | 29.6817 |
2010's | 5 (5.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, CC | 1 |
Dong, Q | 1 |
Liu, DF | 1 |
Luo, YL | 1 |
Liu, LF | 1 |
Chen, AY | 1 |
Yu, C | 1 |
Savaraj, N | 1 |
Chou, TC | 1 |
Yoshida, Y | 1 |
Kawabata, R | 1 |
Yoshikawa, M | 1 |
Kameda, C | 1 |
Koga, C | 1 |
Murakami, M | 1 |
Hitora, T | 1 |
Hirota, M | 1 |
Ikenaga, M | 1 |
Shimizu, J | 2 |
Miwa, H | 1 |
Hasegawa, J | 1 |
Baki, M | 1 |
Kim, YS | 1 |
Kim, JH | 2 |
Ahn, SD | 1 |
Lee, SW | 1 |
Shin, SS | 1 |
Nam, JH | 1 |
Kim, YT | 1 |
Kim, YM | 1 |
Choi, EK | 1 |
Aoyama, T | 1 |
Saeki, H | 1 |
Fujisawa, J | 1 |
Matsukawa, H | 1 |
Rino, Y | 1 |
Masuda, M | 1 |
Kitagawa, H | 1 |
Akimori, T | 1 |
Namikawa, T | 1 |
Okino, T | 1 |
Kobayashi, M | 1 |
Nishioka, A | 1 |
Hanazaki, K | 1 |
Suzuki, S | 1 |
Goto, M | 1 |
Okamoto, T | 1 |
Tomita, I | 1 |
Murayama, A | 1 |
Sawa, M | 1 |
Noguchi, Y | 1 |
Hoshikawa, Y | 1 |
Shimizu, A | 1 |
Nagasaki, T | 1 |
Tsuchiya, T | 1 |
Tagawa, T | 1 |
Honda, S | 1 |
Yamasaki, N | 1 |
Miyazaki, T | 1 |
Hidaka, S | 1 |
Hayashi, T | 1 |
Nagayasu, T | 1 |
Rouquette, I | 1 |
Mazieres, J | 1 |
Matsumori, T | 1 |
Murakami, S | 1 |
Araki, O | 1 |
Tsuda, T | 1 |
Sasaki, A | 1 |
Goto, N | 1 |
Adachi, K | 1 |
Shimada, Y | 1 |
Hayashi, M | 1 |
Itani, T | 1 |
Mimura, J | 1 |
Hashimoto, K | 2 |
Liu, J | 1 |
Yu, RC | 1 |
Rao, XQ | 1 |
Tsujie, M | 1 |
Shibata, N | 1 |
Nomura, T | 1 |
Tanaka, T | 2 |
Morimoto, T | 1 |
Fujita, S | 1 |
Kitani, K | 1 |
Nakahira, S | 1 |
Okuda, H | 1 |
Takeda, M | 1 |
Berkel, S | 1 |
Hummel, F | 1 |
Gaa, J | 1 |
Back, W | 1 |
Hofheinz, R | 1 |
Queisser, W | 1 |
Singer, MV | 1 |
Löhr, M | 1 |
Bugalho, P | 1 |
Chorão, M | 1 |
Fontoura, P | 1 |
Gutova, M | 1 |
Najbauer, J | 1 |
Gevorgyan, A | 1 |
Metz, MZ | 1 |
Weng, Y | 1 |
Shih, CC | 1 |
Aboody, KS | 1 |
Jain, S | 1 |
Agarwal, JP | 1 |
Gupta, T | 1 |
Parikh, PM | 1 |
Mistry, RC | 1 |
Menon, H | 1 |
Pramesh, CS | 1 |
Shrivastava, SK | 1 |
Takeda, K | 1 |
Suyama, H | 1 |
Igishi, T | 1 |
Shigeoka, Y | 1 |
Matsumoto, S | 1 |
Yamasaki, A | 1 |
Sumikawa, T | 1 |
Morita, M | 1 |
Ueda, Y | 1 |
Shimizu, E | 1 |
Zhang, ZY | 1 |
Wang, SZ | 1 |
Zhang, XF | 1 |
Taylor, RE | 1 |
Smith, IE | 1 |
Ford, HT | 1 |
Bryant, BM | 1 |
Casey, AJ | 1 |
Smyth, JF | 1 |
Horai, T | 3 |
Sone, H | 1 |
Takenaga, A | 2 |
Ikegami, H | 3 |
Matsuda, M | 4 |
Hattori, S | 2 |
Miller, TP | 3 |
McMahon, LJ | 1 |
Livingston, RB | 3 |
Karrer, K | 2 |
Pridun, N | 2 |
Denck, H | 1 |
Weick, JK | 1 |
Grozea, PN | 1 |
Carlin, DA | 1 |
McCracken, JD | 1 |
Chen, T | 3 |
White, J | 1 |
Samson, M | 1 |
Stephens, R | 1 |
Coltman, CA | 2 |
Saiki, J | 1 |
Lane, M | 1 |
Bonnet, J | 1 |
McGavran, M | 1 |
Shorthouse, AJ | 1 |
Jones, JM | 1 |
Steel, GG | 1 |
Peckham, MJ | 1 |
White, JE | 1 |
McCracken, J | 1 |
Kennedy, P | 1 |
Seydel, HG | 1 |
Hartman, G | 1 |
Mira, J | 1 |
Khan, M | 1 |
Durrance, FY | 1 |
Skinner, O | 1 |
Fukuda, K | 1 |
Komatubara, S | 1 |
Sato, G | 1 |
Teramoto, S | 1 |
Tatsumura, T | 1 |
Yamamoto, K | 2 |
Murakami, A | 1 |
Tsuda, M | 1 |
Sugiyama, S | 1 |
Nakamura, S | 1 |
Flicker, M | 1 |
Neumann, M | 1 |
Fujisawa, T | 1 |
Yamaguchi, Y | 1 |
Chorba, T | 1 |
Orenstein, JM | 1 |
Harisiadis, L | 1 |
Moody, T | 1 |
Burton, T | 1 |
Schulof, RS | 1 |
Spencer, HJ | 1 |
Mah, K | 1 |
Keane, TJ | 1 |
Van Dyk, J | 1 |
Braban, LE | 1 |
Poon, PY | 1 |
Hao, Y | 1 |
NG, EK | 1 |
Chung, SC | 1 |
Chan, AC | 1 |
Liew, CT | 1 |
Li, AK | 1 |
Hyogo, H | 1 |
Ito, K | 1 |
Kido, S | 1 |
Kida, M | 1 |
Kojima, K | 1 |
Matsuura, M | 1 |
Nakajima, N | 1 |
Akiyama, J | 1 |
Morere, JF | 1 |
Duran, A | 1 |
Tcherakian, F | 1 |
Boaziz, C | 1 |
Valeyre, D | 1 |
Battesti, JP | 1 |
Breu, JL | 1 |
Israel, L | 1 |
Stewart, DJ | 1 |
Dahrouge, S | 1 |
Soltys, KM | 1 |
Evans, WK | 1 |
Lee, DY | 1 |
Kim, HK | 1 |
Paik, HC | 1 |
Kim, HJ | 1 |
Kim, SJ | 1 |
Ohtsu, A | 1 |
Yoshida, S | 1 |
Boku, N | 1 |
Fujii, T | 1 |
Oda, Y | 1 |
Miyata, Y | 1 |
Koba, I | 1 |
Muro, K | 1 |
Ohnaka, O | 1 |
Shimizu, W | 1 |
Arbaje, YM | 1 |
Bittner, G | 1 |
Yingling, JM | 1 |
Storer, B | 1 |
Schiller, JH | 1 |
Chen, YM | 2 |
Whang-Peng, J | 2 |
Liu, JM | 2 |
Kuo, BI | 1 |
Wang, SY | 1 |
Tsai, CM | 2 |
Perng, RP | 2 |
Cwikiel, M | 1 |
Cwikiel, W | 1 |
Albertsson, M | 1 |
Kumegawa, H | 1 |
Mori, S | 1 |
Kanazawa, M | 1 |
Morinaga, K | 1 |
Kobayashi, K | 1 |
Kaba, SE | 1 |
Kyritsis, AP | 1 |
Hess, K | 1 |
Yung, WK | 1 |
Mercier, R | 1 |
Dakhil, S | 1 |
Jaeckle, KA | 1 |
Levin, VA | 1 |
Wu, MF | 1 |
Wu, HW | 1 |
Lin, WC | 1 |
Okuyama, T | 1 |
Korenaga, D | 1 |
Tamura, S | 1 |
Yao, T | 1 |
Maekawa, S | 1 |
Watanabe, A | 1 |
Ikeda, T | 1 |
Sugimachi, K | 1 |
Yoshikawa, T | 1 |
Kato, H | 2 |
Nikkuni, K | 1 |
Sasaki, K | 1 |
Tomidokoro, T | 1 |
Satoh, T | 1 |
Samli, B | 1 |
Celik, S | 1 |
Evrensel, T | 1 |
Orhan, B | 1 |
Tasdelen, I | 1 |
Kim, CJ | 1 |
Kushima, R | 1 |
Okada, Y | 2 |
Seto, A | 1 |
Kitagawa, K | 1 |
Taniguchi, H | 1 |
Koh, T | 1 |
Ohbayashi, T | 1 |
Kunishima, S | 1 |
Yamaguchi, A | 1 |
Masuyama, M | 1 |
Kitamura, K | 1 |
Hagiwara, A | 1 |
Yamaguchi, T | 1 |
Yamagishi, H | 1 |
Fabian, A | 1 |
Ishii, M | 1 |
Iwahana, M | 1 |
Mitsui, I | 1 |
Minami, M | 1 |
Imagawa, S | 1 |
Tohgo, A | 1 |
Ejima, A | 1 |
Nagahama, T | 1 |
Maruyama, M | 1 |
Tokairin, Y | 1 |
Yoshida, T | 1 |
Baba, H | 1 |
Kure, N | 1 |
Ebuchi, M | 1 |
Golbey, RB | 1 |
Lamy, P | 1 |
Lamaze, R | 1 |
Weber, B | 1 |
Bernath, AM | 1 |
Cohen, MH | 1 |
Ihde, DC | 1 |
Fossieck, BE | 1 |
Matthews, MJ | 1 |
Minna, JD | 1 |
Kas'yanenko, IV | 1 |
Breuel, HP | 1 |
Douwes, F | 1 |
Bähre, M | 1 |
San Luis, T | 1 |
Emrich, D | 1 |
Reynolds, RD | 1 |
O'Dell, S | 1 |
Issell, BF | 1 |
Valdivieso, M | 1 |
Bodey, GP | 1 |
Kennedy, PS | 1 |
Deas, BW | 1 |
Giaccone, G | 1 |
Gazdar, AF | 1 |
Beck, H | 1 |
Zunino, F | 1 |
Capranico, G | 1 |
Lower, EE | 1 |
Baughman, RP | 1 |
Cao, YF | 1 |
Xu, CW | 1 |
Liao, ML | 1 |
Fang, MS | 1 |
Yang, XF | 1 |
Wu, SZ | 1 |
Chen, YR | 1 |
Wu, SF | 1 |
Huang, OL | 1 |
Wu, SC | 1 |
Tanaka, N | 1 |
Inoue, F | 1 |
Takeda, I | 1 |
Mori, T | 1 |
Miyake, M | 1 |
Mimura, H | 1 |
Orita, K | 1 |
Rivière, A | 1 |
Abouz, D | 1 |
Ayela, P | 1 |
Berthaud, P | 1 |
Frenay, M | 1 |
Lagrange, JL | 1 |
Pujol, JL | 1 |
Robillard, J | 1 |
Le Chevalier, T | 1 |
Nishimura, M | 1 |
Sugiura, T | 1 |
Urata, A | 1 |
Ota, K | 1 |
Mira, JG | 1 |
Taylor, SL | 1 |
Stephens, RL | 2 |
Ishino, Y | 1 |
Terashima, H | 1 |
Nakata, H | 1 |
Yoshimatsu, H | 1 |
Sanefuji, H | 1 |
Watanabe, Y | 1 |
Sato, H | 1 |
Iida, S | 1 |
Yamada, T | 1 |
Kobayashi, H | 1 |
Kimoto, H | 1 |
Tsunamura, Y | 1 |
Ichihashi, T | 1 |
Hashizume, Y | 1 |
Watson, KJ | 1 |
Shulkes, A | 1 |
Smallwood, RA | 1 |
Douglas, MC | 1 |
Hurley, R | 1 |
Kalnins, R | 1 |
Moran, L | 1 |
Schreml, W | 1 |
Lohrmann, HP | 1 |
Anger, B | 1 |
Kikuchi, K | 1 |
Ogata, T | 1 |
Jin, XJ | 1 |
Chen, TT | 1 |
O'Bryan, RM | 1 |
Vance, RB | 1 |
Weiss, GB | 1 |
Fletcher, WS | 1 |
Inoue, S | 1 |
Takahashi, K | 1 |
Yamanaka, A | 1 |
Shaw, MT | 1 |
Shaw, MK | 1 |
Selawry, OS | 1 |
Elias, EG | 2 |
Brugarolas, A | 1 |
van der Merwe, AM | 1 |
Falkson, G | 1 |
Sandison, AG | 1 |
van Dyk, JJ | 1 |
Falkson, HC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT01849107] | 49 participants (Actual) | Interventional | 2013-04-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
10 reviews available for fluorouracil and Carcinoma, Oat Cell
Article | Year |
---|---|
[A brief overview of a lung cancer biomarker: thymidylate synthase].
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small | 2011 |
[A case report of primary small cell esophageal carcinoma responding successfully to radiochemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cisplatin; | 2012 |
[A patient with stage IVb small cell carcinoma of the esophagus who survived 23 months after systemic cancer chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality | 2003 |
Poorly differentiated small cell carcinoma of the pancreas. A case report and review of the literature.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Small Cell; Fatal Outcome; Fluorouracil; Humans; M | 2004 |
Case report: Second primary small cell carcinoma of the trachea in a breast cancer survivor: a case report and literature review.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Duct | 2008 |
Surgical treatment of stage III lung cancer after chemotherapy and radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Small Cell; Carcinom | 1994 |
[Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin | 1996 |
[A patient with small-cell carcinoma of the esophagus with synchronous liver metastasis surviving 48 months after surgery].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Adminis | 2001 |
Chemotherapy of solid tumors. Recent advances.
Topics: Adult; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinom | 1976 |
The role of chemotherapy in the treatment of lung cancer.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Bleomycin; Carcinoma, Small Cell; Carcinom | 1974 |
19 trials available for fluorouracil and Carcinoma, Oat Cell
Article | Year |
---|---|
[Study on effect of moxibustion and guben yiliu III combined with chemotherapy in treating middle-late stage malignant tumor].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Small Cell | 2001 |
Small cell carcinoma of the lung: results of combination chemotherapy and radiation therapy (COF vs. COFP randomized analyzed).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials | 1984 |
Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vincristine, and mitomycin C (FOMi).
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Therapy | 1980 |
Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: a Southwest Oncology Group Study.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinic | 1982 |
Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality | 1994 |
Cisplatin-5-fluorouracil in small cell lung cancer. A phase II study in 109 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; | 1994 |
A phase II study of 5-fluorouracil plus high-dose folinic acid in the treatment of recurrent small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Female; Fluorouracil; H | 1995 |
TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neop | 1997 |
Ifosfamide-based chemotherapy for previously treated lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcino | 1998 |
[Evaluation of nervous system disorders during the course of gastric carcinoma on the basis of clinical electrophysiologic analysis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Ad | 1999 |
[Chemotherapy of non-microcellular disseminated bronchial cancer (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Bleomycin; Bronchial Neoplasms; Carcinoma, Small Cell; Carcinoma, Squam | 1979 |
[The combined treatment of bronchial carcinoma (author's transl)].
Topics: Adenocarcinoma; Aged; Bronchial Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical | 1975 |
Conservative treatment of patients with small-cell lung cancer.
Topics: Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lu | 1976 |
Combination modality therapy in lung cancer: a survival study showing beneficial results of AMCOF (adriamycin, methotrexate, cyclophosphamide, oncovin and 5-fluorouracil).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Small Cell; Carcinoma, S | 1978 |
Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin | 1978 |
[Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squam | 1989 |
[Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Ca | 1985 |
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cl | 1986 |
Advanced lung cancer: A clinical trial of radiotherapy plus two drug combination regimens.
Topics: Adenocarcinoma; Amides; Antineoplastic Agents; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous | 1973 |
57 other studies available for fluorouracil and Carcinoma, Oat Cell
Article | Year |
---|---|
Design of antineoplastic agents on the basis of the "2-phenylnaphthalene-type" structural pattern. 2. Synthesis and biological activity studies of benzo]b]naphtho[2,3-d]furan-6,11-dione derivatives.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; DNA Topoisomerases, Type II; Furans; Humans | 1993 |
[A Case of Penetrating Diverticulum of the Small Intestine that Occurred during Chemotherapy for Esophageal Cancer].
Topics: Abdominal Abscess; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcin | 2015 |
[Report from the 44th Congress of the American Society of Clinical Oncology].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Breast Neoplasms | 2008 |
High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carc | 2009 |
[A long-term recurrence-free survivor after chemotherapy with 5-FU plus CDDP and surgery for small cell carcinoma of the esophagus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Small Cell; Cisplatin; Esophageal | 2009 |
[A case of small cell undifferentiated carcinoma of the esophagus successfully treated by chemoradiotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Small Cell | 2009 |
[A case of small cell carcinoma of the esophagus with SIADH].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplas | 2010 |
Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Carcinoma, Large Cell; Carcinoma, Neuroendocr | 2010 |
Miliary brain metastases from primary gastric small cell carcinoma: illustrating the seed and soil hypothesis.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Neur | 2005 |
Identification of uPAR-positive chemoresistant cells in small cell lung cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transport | 2007 |
Sequential treatment with SN-38 followed by 5-fluorouracil shows synergistic cytotoxic activity in small cell lung cancer cells.
Topics: Amidohydrolases; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell | 2008 |
Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lung.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Com | 1980 |
Cytologic characteristics of oat-cell carcinoma of the lung in relation to the effect of chemotherapy.
Topics: Aged; Antineoplastic Agents; Bronchoscopy; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Co | 1981 |
[Combined chemotherapy of bronchial carcinomas (author's transl)].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Small Cell; Carcinoma, | 1980 |
Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Administration Sched | 1982 |
Experimental combination and single-agent chemotherapy in human lung-tumour xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carc | 1982 |
The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung: preliminary report of a Southwest Oncology Group study.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Drug Administration Schedule; Drug T | 1982 |
[Pre- and intra-operative chemotherapy using FT-207 suppositories--with special reference to lung cancer].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Fluorouracil | 1982 |
[New chemotherapeutic method for the treatment of tracheal and bronchial cancers--nebulization chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Small Cell; Carcinoma, | 1983 |
[Chemotherapy of small cell carcinoma of the lung in relation to lymph node metastasis and extending pattern of tumor].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Lung Neopl | 1983 |
[Chemotherapy of small cell carcinomas of the lung].
Topics: Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Co | 1983 |
[Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1983 |
An atypical endocrine tumor of the lung responsive to radiation therapy and 5-fluorouracil-streptozotocin.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bombesin; Carcinoma, | 1984 |
Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Drug Hypersensitivity; Erythema Multiforme | 1984 |
Pre-operative induction chemotherapy for small cell carcinoma of the oesophagus: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality | 1995 |
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplat | 1995 |
Small cell carcinoma of the esophagus with an esophago-mediastinal fistula successfully treated by chemoradiation therapy and intubation: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cobalt Radioisotop | 1993 |
Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel | 1993 |
Serum cytokine level fluctuations in chemotherapy-induced myelosuppression.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Carcino | 1996 |
Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agen | 1996 |
[A case report of small cell carcinoma of the esophagus with remarkable response to neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cispl | 1996 |
The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: report of a case.
Topics: Adenoma, Villous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcino | 1999 |
[A case report of esophageal small cell carcinoma responding well to chemotherapy of 5-FU and cisplatin combined with radiotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 1999 |
Primary neuroendocrine small cell carcinoma of the breast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, | 2000 |
Establishment and characterization of a prostatic small-cell carcinoma cell line (PSK-1) derived from a patient with Klinefelter syndrome.
Topics: Adult; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Cisplatin; Dacarbazine; | 2000 |
[A case of successful management of nonresectable advanced cholangiocellular carcinoma by intermittent hepatic arterial infusion at home].
Topics: Aged; Aged, 80 and over; Ambulatory Care; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Carc | 2000 |
Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Casset | 2000 |
Chemotherapy for lung cancer.
Topics: Bleomycin; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Dactinomyci | 1978 |
Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Drug Therapy, Combination; Female; Fluorouracil; | 1976 |
Small cell carcinoma of the lung: clinical and cytomorphological studies in relation to its response to chemotherapy.
Topics: Adult; Aged; Carcinoma, Small Cell; Cell Nucleus; Cyclophosphamide; Cytoplasm; Female; Fluorouracil; | 1977 |
Case report: Liver scintigraphy in the follow-up of a patient on cytotoxic therapy.
Topics: Adenocarcinoma; Bronchial Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Fluorouracil; Humans; | 1976 |
COMF-radiotherapy treatment of small cell carcinoma of the lung.
Topics: Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Lung Neopl | 1979 |
Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
Topics: Adenocarcinoma; Antineoplastic Agents; Blotting, Northern; Blotting, Southern; Camptothecin; Carcino | 1992 |
The effect of cancer and chemotherapy on monocyte function.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Small Cell; Cyclophosph | 1990 |
[Chemotherapy combined with selective resection in small cell lung cancer--analysis of 239 patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality | 1986 |
[Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1988 |
[Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Ca | 1985 |
Simultaneous chemotherapy-radiotherapy with prophylactic cranial irradiation for inoperable adeno and large cell lung carcinoma: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcin | 1988 |
[State III large cell carcinoma of the lung cured by radiotherapy--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; | 1988 |
Watery diarrhea-hypokalemia-achlorhydria syndrome and carcinoma of the esophagus.
Topics: Achlorhydria; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; | 1985 |
Stem cell defects after cytoreductive therapy in man.
Topics: Animals; Antineoplastic Agents; Blood Cells; Bone Marrow; Breast Neoplasms; Carcinoma, Small Cell; C | 1985 |
[Postoperative chemotherapy of pathological stage I non-small cell carcinoma of the lung].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1986 |
[Combination therapy of small cell anaplastic carcinoma of the lung and the role of prophylactic whole brain irradiation--report of 39 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinoma, Small Cell | 1985 |
[UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Female; | 1987 |
5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1987 |
The role of heparin in the chemotherapy of solid tumors: preliminary clinical trial in carcinoma of the lung.
Topics: Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Fibrinogen; Fluorouracil; H | 1972 |
Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
Topics: Aged; Antineoplastic Agents; Blood Coagulation; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Small | 1974 |